Cargando…
LAT1 (SLC7A5) Overexpression in Negative Her2 Group of Breast Cancer: A Potential Therapy Target
OBJECTIVE: HER2 negative carcinomas of the breast pose a challenge for treatment due to redundancies in potential drug targets and poor patient outcomes. Our aim was to investigate the role of L-type amino acid transporter – LAT1 as a potential prognosticator and a drug target. METHODS: In this retr...
Autores principales: | Bodoor, Khaldon, Almomani, Rowida, Alqudah, Mohammad, Haddad, Yazan, Samouri, Walaa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541863/ https://www.ncbi.nlm.nih.gov/pubmed/32458655 http://dx.doi.org/10.31557/APJCP.2020.21.5.1453 |
Ejemplares similares
-
TIMAP Upregulation Correlates Negatively with Survival in HER2- Negative Subtypes of Breast Cancer
por: Obeidat, Marya, et al.
Publicado: (2021) -
Evaluation of Patched-1 Protein Expression Level in Low Risk and High Risk Basal Cell Carcinoma Subtypes
por: Almomani, Rowida, et al.
Publicado: (2019) -
Clinical and Demographic Features of Basal Cell Carcinoma in North Jordan
por: Al-Qarqaz, Firas, et al.
Publicado: (2018) -
Basal Cell Carcinoma Pathology Requests and Reports Are Lacking Important Information
por: Al-Qarqaz, Firas, et al.
Publicado: (2019) -
Erratum to “Basal Cell Carcinoma Pathology Requests and Reports Are Lacking Important Information”
por: Al-Qarqaz, Firas, et al.
Publicado: (2019)